Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy

Objective: This study’s objective was to evaluate the effects of pharmacokinetic and pharmacogenetic factors on major bleeding in patients with ACS and non-valvular AF receiving combined antithrombotic therapy consisting of rivaroxaban, clopidogrel, and aspirin as part of dual or triple therapy. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Baturina, Olga, Chashkina, Maria, Andreev, Denis, Mirzaev, Karin, Bykova, Alexandra, Suvorov, Alexandr, Yeryshova, Daria, Suchkova, Svetlana, Sychev, Dmitry, Syrkin, Abram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532904/
https://www.ncbi.nlm.nih.gov/pubmed/37763139
http://dx.doi.org/10.3390/jpm13091371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532904/
https://www.ncbi.nlm.nih.gov/pubmed/37763139
http://dx.doi.org/10.3390/jpm13091371

Ejemplares similares